Brief: Edap Announces First Patients Treated In Phase 2 Study Of Focal One For The Treatment Of Deep Invasive Endometriosis
03/09/2020 13:40
Sept 3 (Reuters) - Edap Tms SA EDAP.O :
* EDAP ANNOUNCES FIRST PATIENTS TREATED IN PHASE 2 STUDY OF
FOCAL
ONE FOR THE TREATMENT OF DEEP INVASIVE ENDOMETRIOSIS
Source text for Eikon: ID:nGNX9LPfx1
Further company coverage: EDAP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Edap Tms SA
See all newsEdap Tms SA reports results for the quarter ended June 30 - Earnings Summary
FocalTherics slides after $40 million share sale
Brief: Focaltherics™ Announces Pricing Of Public Offering Of American Depositary Shares
Brief: Focaltherics™ Announces Proposed Public Offering Of American Depositary Shares
Edap Tms SA expected to post a loss of 20 cents a share - Earnings Preview